We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Benchmark Holdings Plc | LSE:BMK | London | Ordinary Share | GB00BGHPT808 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 45.50 | 45.00 | 46.00 | 0.00 | 08:17:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 169.74M | -23.15M | -0.0313 | -14.54 | 336.41M |
TIDMBMK
RNS Number : 4998I
Benchmark Holdings PLC
19 June 2017
Benchmark Holdings plc
("Benchmark", the "Company" or the "Group")
Notice of Results
Following the Trading Update and Notice of Results announcement made on 25 May 2017, Benchmark confirms it will announce its Interim Results for the six months to 31 March 2017 on Tuesday 27 June.
A meeting for Analysts will be held on that day at 10am, with a dial-in feature available.
For further details on the analyst meeting or dial-in details, please contact Sophie Praill or Niall Walsh on +44 (0)20 7920 3150.
- Ends - For further information, please contact: Benchmark Holdings plc Tel: 020 7920 3150 Malcolm Pye, CEO Roland Bonney, COO Rachel Aninakwah, Communications Tavistock Tel: 020 7920 3150 Simon Hudson / Niall Walsh / Sophie Praill
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORXKLFFDQFZBBQ
(END) Dow Jones Newswires
June 19, 2017 10:00 ET (14:00 GMT)
1 Year Benchmark Chart |
1 Month Benchmark Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions